This trial is studying two sets of treatment algorithms for brain metastases patients who have had stereotactic radiosurgery.
- Metastatic Brain Tumors
- Recurrent Tumor
- Metastatic Recurrence
- Radiation Necrosis
2 Primary · 1 Secondary · Reporting Duration: From enrollment through 24 months or study exit (whichever comes first). Measurements occur at baseline, post-op visit, 1 month visit, and each subsequent follow up visit until study exit or at 24 months, whichever comes first.
Awards & Highlights
0 Treatment Group
154 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any openings left in this medical research study?
"The clinical trial is currently enrolling patients, and information available on the website indicates that it was initially posted in May of 2022 with a recent update occurring June 23rd." - Anonymous Online Contributor
What is the current recruitment quota for this trial?
"Indeed, the clinicaltrials.gov website reveals that this medical research is actively enrolling patients. This trial was initially posted on May 10th 2022 and most recently updated on June 23rd of the same year; aiming to recruit 154 individuals from two distinct sites." - Anonymous Online Contributor